...
首页> 外文期刊>Bulletin of the Chemical Society of Japan >Identification of a Novel SHP-2 Protein Tyrosine Phosphatase Inhibitor
【24h】

Identification of a Novel SHP-2 Protein Tyrosine Phosphatase Inhibitor

机译:新型SHP-2蛋白酪氨酸磷酸酶抑制剂的鉴定

获取原文
获取原文并翻译 | 示例
           

摘要

The Src homology 2 (SH2) domain-containing phosphatase 2 (SHP-2) is a nonreceptor protein tyrosine phosphatase (PTP) involved in extracellular-regulated kinase (ERK) activation. Recent studies have shown that gain-of-function mutations in SHP-2 are associated with several diseases, including LEOPARD syndrome, Noonan syndrome, and juvenile myelomonocytic leukemia. In this study, we identified the novel SHP-2 inhibitor 3-(1-benzimidazolylmethyl)-6-p-tolyl-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole (MLS-001). SHIP-2 activity was inhibited by MLS-001, whereas other types of PTPs, namely ACP1, CDC25A, DUSP3, DUSP14, DUSP18, DUSP22, DUSP23, DUSP26, and SSH3, were not. Furthermore, TCPTP and SHP-1 that are closely related to SHP-2 were not inhibited by the inhibitor. Kinetic studies with MLS-001 and SHP-2 revealed a competitive inhibition. The SHP-2 expressing cells treated with MLS-001 demonstrated reduced SHP-2 phosphatase activity, thereby suggesting that MLS-001 effectively passes through cell membranes. In addition, MLS-001 reduced SHP-2-mediated phosphorylation in the activation loop of ERK in cells. Therefore, MLS-001 could be a lead compound for developing a potent SHP-2 inhibitor.
机译:SRC同源性2(SH2)含有结构域的磷酸酶2(SHP-2)是参与细胞外调节激酶(ERK)活化的非接受蛋白酪氨酸磷酸酶(PTP)。最近的研究表明,SHP-2中的功能性突变与几种疾病有关,包括豹综合征,非洲综合征和青少年骨髓细胞白血病。在这项研究中,我们鉴定了新的SHP-2抑制剂3-(1-苯并咪唑基甲基)-6-P-甲苯基 - [1,2,4]三唑唑[3,4-B] [1,3,4]噻二唑( MLS-001)。通过MLS-001抑制船舶2活性,而其他类型的PTP,即ACP1,CDC25A,DUSP3,DUSP14,DUSP18,DUSP22,DUSP23,DUSP26和SSH3则不是。此外,抑制剂不抑制与SHP-2密切相关的TCPTP和SHP-1。 MLS-001和SHP-2的动力学研究显示出具有竞争性抑制作用。用MLS-001处理的SHP-2表达细胞证明了SHP-2磷酸酶活性降低,从而表明MLS-001有效地通过细胞膜。另外,MLS-001在电池中ERK的活化环中减少了SHP-2介导的磷酸化。因此,MLS-001可以是用于开发有效的SHP-2抑制剂的铅化合物。

著录项

  • 来源
  • 作者单位

    Chung Ang Univ Coll Pharm Seoul 156756 South Korea;

    Chung Ang Univ Coll Pharm Seoul 156756 South Korea;

    Chung Ang Univ Coll Pharm Seoul 156756 South Korea;

    Korea Res Inst Biosci &

    Biotechnol Med Prote Res Ctr Taejon 305333 South Korea;

    Korea Res Inst Biosci &

    Biotechnol Med Prote Res Ctr Taejon 305333 South Korea;

    Korea Res Inst Biosci &

    Biotechnol Med Prote Res Ctr Taejon 305333 South Korea;

    Chung Ang Univ Coll Pharm Seoul 156756 South Korea;

    Chung Ang Univ Coll Pharm Seoul 156756 South Korea;

    Chung Ang Univ Coll Pharm Seoul 156756 South Korea;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 化学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号